Ironwood Pharmaceuticals Inc (NAS:IRWD)
$ 4.45 -0.14 (-3.05%) Market Cap: 712.13 Mil Enterprise Value: 1.26 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 54/100

Q2 2024 Ironwood Pharmaceuticals Inc Earnings Call Transcript

Aug 08, 2024 / 12:30PM GMT
Release Date Price: $4.05 (-32.61%)
Operator

Thank you for standing by. My name is Celine, and I will be your conference operator today. At this time, I would like to welcome everyone to the Ironwood Pharmaceuticals Q2 2024 earnings call for investor update conference call. (Operator Instructions)

I would now like to turn the call over to Matt Roache, Director of Investor Relations. Please go ahead.

Matt Roache
Ironwood Pharmaceuticals Inc - Director, Investor Relations

Thank you, Celine.

Good morning and thanks for joining us for our second-quarter 2024 investor update. Our press release issued this morning can be found on our website.

Today's call and accompanying slides include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements involve risks and uncertainties that may cause actual results to differ materially. The discussion of these statements and risk factors is available on the current Safe Harbor statement slide, as well as under the heading Risk Factors in our annual report on Form 10-K for the year

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot